Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 3.23B | £ 3.37B | £ 4.07B | £ 4.53B | £ 6.47B |
Total Assets | £ 53.53B | £ 49.77B | £ 51.58B | £ 50.88B | £ 53.51B |
Total Debt | £ 23.88B | £ 21.39B | £ 22.83B | £ 22.84B | £ 25.43B |
Net Debt | £ 20.64B | £ 18.02B | £ 18.76B | £ 18.30B | £ 18.96B |
Total Liabilities | £ 37.69B | £ 34.48B | £ 39.52B | £ 39.20B | £ 41.44B |
Stockholders Equity | £ 15.84B | £ 15.30B | £ 12.06B | £ 11.68B | £ 12.07B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |